Cyxone AB (FRA:4CX) Cash Flow for Dividends : €0.00 Mil (TTM As of Jun. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Cyxone AB Cash Flow for Dividends?

Cyxone AB's cash flow for dividends for the three months ended in Jun. 2024 was €0.00 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Jun. 2024 was €0.00 Mil.

Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.

Cyxone AB Cash Flow for Dividends Historical Data

The historical data trend for Cyxone AB's Cash Flow for Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cyxone AB Cash Flow for Dividends Chart

Cyxone AB Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cash Flow for Dividends

Get a 7-Day Free Trial

Cyxone AB Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Cash Flow for Dividends	Get a 7-Day Free Trial															-	-	-	-	-

Cyxone AB Cash Flow for Dividends Calculation

Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Cash Flow for Dividends for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.00 Mil.

Cyxone AB Cash Flow for Dividends Related Terms

Thank you for viewing the detailed overview of Cyxone AB's Cash Flow for Dividends provided by GuruFocus.com. Please click on the following links to see related term pages.

Cyxone AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cyxone AB (FRA:4CX) » Definitions » Cash Flow for Dividends

Comparable Companies

Traded in Other Exchanges

CYXO:Sweden

Address

Hyllie Boulevard 34, Malmo, SWE, 215 32

Website

https://www.cyxone.com

Cyxone AB is a clinical biotech company with a portfolio of immunomodulating drugs for the treatment of autoimmune diseases such as multiple sclerosis (MS) and rheumatoid arthritis (RA). The product candidates of the company include T20K and Rabeximod.

Cyxone AB Headlines

No Headlines